fda semaglutide update The FDA's Decision to Ban Compounds: What You Need to Know Shortage update from https://www.accessdata.fda.gov/ website

(It doesn't mix well when you try to stir it into cold liquids, so youll need to use a blender.) Having it with a meal may help support more stable blood sugar levels after you eat

That is not changing

Saxenda: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, upset stomach, fatigue, dizziness, abdominal pain, increased lipase (a digestive enzyme), upper abdominal pain, fever, and gastroenteritis (inflammation of the stomach and intestines)

The consensus rating on LLY shares sits at Strong Buy currently, with the mean price target of 1,232 indicating potential upside of more than 30% from current levels

Reductions in A1c levels were similar in any duration of diabetes in DUAL-1 and 2

However, as we discuss, neither compound can be legally sold in the U.S